EUVIMEDEUVIMED entdecken
Open Access

SPRR1A is a potential therapeutic target for osteosarcoma: in vitro and in vivo evaluations using generated artificial osteosarcoma cancer stem cell‑like cells

Tomohiro Miyamoto, Naomasa Fukase, Teruya Kawamoto, Shuichi Fujiwara, Hitomi Hara, Ryoko Sawada, Yuta Nakamatsu, Yutaka Mifune, Kenichiro Kakutani, Yuichi Hoshino, Shinya Hayashi, Tomoyuki Matsumoto und 7 weitere

Oncology Reports · 2024

DOI: 10.3892/or.2024.8857 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2024. Verfasst von Tomohiro Miyamoto und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine, Kobe 650‑0017, Japan. Hauptthemen laut MEDLINE: Osteosarcoma, Neoplastic Stem Cells, Cell Proliferation, Cell Movement. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaNeoplastic Stem CellsCell ProliferationCell MovementCornified Envelope Proline-Rich ProteinsBone NeoplasmsHumansAnimalsMiceCell Line, TumorXenograft Model Antitumor AssaysGene Expression Regulation, NeoplasticMice, NudeRNA, Small Interfering

Stichwörter der Autor:innen

CSCOSSPRR1Afocal adhesiontumor progression

Substanzen

Cornified Envelope Proline-Rich ProteinsRNA, Small Interfering

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine, Kobe 650‑0017, Japan.
  • Department of Orthopaedic Surgery, Konan Medical Center, 658‑0064 Kobe, Japan.
  • Division of Stem Cell Medicine, Kobe University Graduate School of Medicine, Kobe 650‑0017, Japan.
  • Department of Orthopaedic Surgery, Hyogo Cancer Center, Akashi 673‑8558, Japan.

Zitieren

APA

Miyamoto, T., Fukase, N., Kawamoto, T., Fujiwara, S., Hara, H., Sawada, R., Nakamatsu, Y., Mifune, Y., Kakutani, K., Hoshino, Y., Hayashi, S., Matsumoto, T., Matsushita, T., Koyanagi-Aoi, M., Aoi, T., Takemori, T., Yahiro, S., Kuroda, R., & Akisue, T. (2024). SPRR1A is a potential therapeutic target for osteosarcoma: in vitro and in vivo evaluations using generated artificial osteosarcoma cancer stem cell‑like cells. Oncology Reports. https://doi.org/10.3892/or.2024.8857

Vancouver

Miyamoto T, Fukase N, Kawamoto T, Fujiwara S, Hara H, Sawada R, et al. SPRR1A is a potential therapeutic target for osteosarcoma: in vitro and in vivo evaluations using generated artificial osteosarcoma cancer stem cell‑like cells. Oncology Reports. 2024. doi:10.3892/or.2024.8857

BibTeX
@article{Miyamoto2024,
  author = {Miyamoto, Tomohiro and Fukase, Naomasa and Kawamoto, Teruya and Fujiwara, Shuichi and Hara, Hitomi and Sawada, Ryoko and Nakamatsu, Yuta and Mifune, Yutaka and Kakutani, Kenichiro and Hoshino, Yuichi and Hayashi, Shinya and Matsumoto, Tomoyuki and Matsushita, Takehiko and Koyanagi-Aoi, Michiyo and Aoi, Takashi and Takemori, Toshiyuki and Yahiro, Shunsuke and Kuroda, Ryosuke and Akisue, Toshihiro},
  title = {SPRR1A is a potential therapeutic target for osteosarcoma: in vitro and in vivo evaluations using generated artificial osteosarcoma cancer stem cell‑like cells},
  journal = {Oncology Reports},
  year = {2024},
  doi = {10.3892/or.2024.8857}
}
Kostenlos starten →